New iPS-cell model system helps develop treatments for spinocerebellar ataxia
Researchers at the RIKEN Center for Developmental Biology have succeeded in creating a new model system that can be used to develop drug therapies for genetic disorders like spinocerebellar ataxia type 6 (SCA6). Published ...
Nov 1, 2016
0
1